Skip to main content
. Author manuscript; available in PMC: 2014 Mar 5.
Published in final edited form as: J Am Coll Cardiol. 2013 Mar 5;61(9):971–980. doi: 10.1016/j.jacc.2012.12.018

Table 1.

Quantification of (14)-Day Endothelial Cell Proliferation (%)

p Value
Group %, Mean ± SD vs. BMS
Control		 vs. BMS
Mf		 vs. ZES
Control
BMS-control (n = 3) 48.3 ± 6.8
BMS-Mf (n = 3) 43.0 ± 7.9 0.6629 
ZES-control (n = 3) 20.1 ± 0.9 0.0011* 0.0043*
ZES-Mf (n = 3) 11.6 ± 3.9 0.0002* 0.0006* 0.3112
*

Statistically significant (p < 0.05).

BMS = bare-metal stent(s); Mf = metformin; ZES = zotarolimus-eluting stent(s).